Data / Form D filings / Bio Usawa Inc.
Bio Usawa Inc.: Form D filings
Bio Usawa Inc., a biotechnology company in San Francisco, CA, filed 4 Form D notices with the SEC between 2025 and 2026. The latest, on January 27, 2026, reports $500,000 sold of an offering with no set size to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 PINE STREET SUITE 1250, San Francisco, CA, 94111
- Phone
- (240) 505-4396
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2095500
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | Amendment | Indefinite | $500,000 | 7 | Oct 30, 2025 | sec.gov | |
| Dec 17, 2025 | New notice | $450,000 | $450,000 | 6 | Oct 30, 2025 | sec.gov | |
| Dec 17, 2025 | New notice | $1,705,000 | $1,705,000 | 25 | Feb 21, 2024 | sec.gov | |
| Dec 17, 2025 | New notice | $403,900 | $403,900 | 5 | Jan 16, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Menghis Bairu | Executive Officer, Director | |
| Richard Chin | Director | |
| John Hautman | Executive Officer | |
| Vincent Ancinetti | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jan 26, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Bio Usawa Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.